Selecciona el artículo para ver su contenido
| Hepatology Highlights | 2,207 visitas |
| Annals Impact Factor 1.67. | 1,254 visitas |
| Is pre-treatment liver biopsy necessary for all hepatitis C genotypes? | 1,253 visitas |
| Comparison of acoustic radiation force impulse imaging (ARFI) to liver biopsy histologic scores in the evaluation of chronic liver disease: | 1,147 visitas |
| The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: | 1,095 visitas |
| Hepatology Highlights | 982 visitas |
| Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode | 947 visitas |
| A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection | 912 visitas |
| The Annals of Hepatology welcomes the Canadian Association for the Study of the Liver (CASL) | 895 visitas |
| Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis | 889 visitas |
| Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence | 884 visitas |
| Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients | 860 visitas |
| A review of drug interactions with boceprevir and telaprevir: | 846 visitas |
| Acetylcholine receptor antibody positive generalized Myasthenia gravis in association with Primary Biliary Cirrhosis | 839 visitas |
| Spontaneous clearance of hepatitis C infection post-liver transplant: A rare but real phenomenon? | 839 visitas |
| First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplanterferon a, ribavirin and telaprevir | 833 visitas |
| Adult live donor liver transplantation: | 824 visitas |
| Hepatic lymphoma in a post renal transplant patient with chronic hepatitis B | 822 visitas |
| Non-invasive assessment of liver fibrosis using ARFI with pathological correlation, a prospective study | 814 visitas |
| Treatment issues surrounding hepatitis C in renal transplantation: | 808 visitas |
| The direct-acting antivirals for hepatitis C virus and the risk for hepatocellular carcinoma | 775 visitas |
| Hepatology Highlights | 755 visitas |
| Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: | 708 visitas |
| Hepatology Highlights | 674 visitas |
| Persistence of virologic response after liver transplant in hepatitis C patients treated with ledipasvir/sofosbuvir plus ribavirin pretransplant | 645 visitas |
| The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation | 643 visitas |
| Hepatology Highlights | 615 visitas |
| A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV | 601 visitas |
| Hepatology highlights | 598 visitas |
| Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir | 585 visitas |
| Hepatitis B in pregnancy: | 584 visitas |
| Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: | 570 visitas |
| First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder | 500 visitas |
| Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review | 482 visitas |
| Transplanting Kidney Allografts from Hepatitis C Infected Donors into Hepatitis C Uninfected Recipients: | 313 visitas |
Eric M Yoshida
- Originario de:
- Semblanza:
- Enfermedades tratadas:
- Curriculum:
¡Actualice sus datos!
Con el objetivo de difundir los datos actualizados de los autores a los pacientes, amigos, alumnos o colegas te invitamos a proporcionar o confirmar al menos su
nombre, correo y semblanza